On August 24, 2023 Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, reported that management will participate in the following investor conferences (Press release, Alpha Tau Medical, AUG 24, 2023, View Source [SID1234634672]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Citi’s 2023 Annual BioPharma Conference
Format: 1-on-1 meetings
Date: September 6th, 2023
Location: Boston, MA

Event: Emerging Growth Conference
Format: Company presentation and 1-on-1 meetings
Date: September 7th, 2023
Time 2:20 – 2:50 PM ET
Location: Virtual

Event: Cantor Fitzgerald Global Healthcare Conference
Format: Fireside chat and 1-on-1 meetings
Date: September 27th, 2023
Time: 3:35 – 4:05 PM ET
Location: New York, NY

Please reach out to your Citi and Cantor representatives to schedule, and register here to ensure you are able to attend the Emerging Growth conference and receive any updates that are released.

View Source;tp_key=ab3efc5870&sti=drts

If attendees are not able to join the Emerging Growth Conference live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, View Source